Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography

NCT02282163 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped FDA agreed to early termination due to difficulties enrolling patients.

Conditions

Heart Disease

Interventions

DRUG: sulphur hexafluoride lipid-type A microspheres

Sponsor

Bracco Diagnostics, Inc